IRE1α Inhibitors

The class of IRE1α inhibitors encompasses a diverse array of chemical compounds designed to modulate the cellular functions of Inositol-Requiring Enzyme 1 alpha (IRE1α), a key sensor of endoplasmic reticulum (ER) stress and a critical component of the unfolded protein response (UPR). These inhibitors, whether acting directly on IRE1α or influencing associated pathways, play a pivotal role in unraveling the molecular intricacies of cellular stress responses and have implications for interventions in diseases associated with ER stress.

Direct inhibitors such as MKC-3946, STF-083010, 4μ8C, KIRA6, B-I09, MKC8866, and SW-116 target specific domains of IRE1α, disrupting its endoribonuclease or kinase activities. For instance, MKC-3946 binds to the endoribonuclease domain, inhibiting the processing of XBP1 mRNA and consequently impacting downstream UPR signaling. STF-083010, on the other hand, selectively targets the kinase domain, disrupting IRE1α signaling and influencing ER stress responses. These direct inhibitors provide invaluable tools for researchers to dissect the functional consequences of IRE1α activity and explore interventions for conditions associated with ER stress. Compounds like Salicylaldehyde isonicotinoyl hydrazone (SIH) and Tauroursodeoxycholic acid (TUDCA) have demonstrated the ability to modulate IRE1α activity, although the precise mechanisms are not fully elucidated. These compounds may act indirectly, possibly through interactions with cellular components involved in the regulation of ER stress responses.